VIMGF (Vimian Group AB) Stock Based Compensation: $0.0 Mil (TTM As of Mar. 2026)


VIMGF Vimian Group AB VIMGF
69 GF Score
Price $2.77
GF Value $3.19
! 2 Warning Signs
View Full Analysis

What is Vimian Group AB Stock Based Compensation?

Vimian Group AB VIMGF 69 Stock Based Compensation is $0.0 Mil as of Mar. 2026. GuruFocus rates VIMGF with a GF Score™ of 69/100 and a GF Value™ of $3.19. The stock has 2 warning signs investors should review.

Vimian Group AB's Stock Based Compensation for the three months ended in Mar. 2026 was $0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

Vimian Group AB Stock Based Compensation Related Terms

Vimian Group AB Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Vimian Group AB's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimian Group AB Stock Based Compensation Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vimian Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
VIMGF
69GF Score
Vimian Group AB VIMGF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimian Group AB Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

What does a Stock Based Compensation of $0.0 Mil mean?
Vimian Group AB (VIMGF) has a Stock Based Compensation of $0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Vimian Group AB and its competitors.
Is Vimian Group AB's Stock Based Compensation too high?
Vimian Group AB's current Stock Based Compensation is $0.0 Mil. Overall, Vimian Group AB has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Vimian Group AB's Stock Based Compensation compare to TMO and DHR?
Vimian Group AB's Stock Based Compensation of $0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Diagnostics & Research company?
A good Stock Based Compensation depends on the Medical Diagnostics & Research industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Vimian Group AB and its competitors. Vimian Group AB's current Stock Based Compensation is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimian Group AB stock overvalued right now?
Vimian Group AB (VIMGF) has a current Stock Based Compensation of $0.0 Mil. The stock's GF Value™ is $3.19, compared to a current price of $2.77 — trading 13.2% below its estimated fair value. The current Stock Based Compensation is $0.0 Mil. Vimian Group AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Vimian Group AB (VIMGF), the current Stock Based Compensation is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimian Group AB (VIMGF) Overvalued in 2026?

Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued. The current stock price of $2.77 is trading 13.2% below its estimated GF Value™ of $3.19.

Key valuation signals for VIMGF:

  • Stock Based Compensation: $0.0 Mil
  • GF Value™: $3.19 vs. price of $2.77 (13.2% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the VIMGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimian Group AB Business Description

Address Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
69GF Score

Get the complete analysis for VIMGF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77
Price
$3.19
GF Value